Unbiased AI-powered news
Argentine legislators changed the 2010 Glacier Law last month, opening periglacial zones to mining activities after technical reviews. The move follows years of protection for the country's 16,000 glaciers, which cover 8,484 square kilometers and serve as vital freshwater reserves.
indianexpress.comArgentine legislators amended the Glacier Law that had prohibited all mining and exploration activities in the country’s glacier regions since 2010. The amendment to the glacier protection law passed last month by the Argentine National Congress. The new Argentine law permits mining activities within periglacial areas subject to technical assessments.
Beneath the shining white glaciers of the Andean mountains lie valuable deposits of gold, copper and molybdenum. Andres Folguera, a professor with the department of geological sciences at the University of Buenos Aires, stated that the minerals are not extracted today because they compromise water resources protected by the former law or because they are difficult to access.
The Glacier Law of 2010 defined the country’s glaciers as public goods because of their importance as freshwater reserves, their role in biodiversity, their scientific value and their appeal as tourist attractions.
Argentina has 16,000 glaciers that cover an area of 8,484 sq km, or 5,270 square miles. Scientists warn that allowing access to deposits near vital ice reserves threatens food production sustaining 400 million people. Half a world away, Indigenous leaders in Alaska secured lasting protections for one of the planet’s most productive salmon watersheds.
In 2001 a Canadian mining company proposed a massive gold and copper mine at the headwaters of Bristol Bay, Alaska. The proposed mine is called the Pebble Mine and would have been the largest open-pit mine in North America. Bristol Bay is home to the largest sockeye salmon run in the world and produces more than $2 billion of annual revenue from sockeye salmon fishing.
The Pebble project would require storing tens of billions of tons of toxic waste in perpetuity and would be located at the connected headwaters of the Nushagak and Kvichak river systems. Alannah Hurley, executive director of the United Tribes of Bristol Bay, won the 2026 Goldman Environmental Prize for North America. Her Yup’ik name is Acaq.
Three different Indigenous groups live in Bristol Bay: the Yup’ik people, the Dena’ina people, and the Alutiiq people. "Our homeland has been stewarded by our people for thousands and thousands of years," Hurley said. " Indigenous communities in Bristol Bay have stewarded the land and water for thousands of years.
In 2010 the tribes of Bristol Bay petitioned the EPA to prohibit all mines like Pebble within the Bristol Bay watershed. The EPA finalized protections to stop the Pebble Mine project in January 2023. Northern Dynasty Minerals is the Canadian mining company that proposed the Pebble Mine.
The company, Northern Dynasty, the state of Alaska and a few others have challenged the EPA protections in court, Hurley said. Hurley’s grandmother was Mancuaq and she passed away in 2019. "It’s hard for me not to get emotional talking about her, because even now, even in all the different experiences in my life, everything important, the most important things that have helped me navigate life in a way that has been good and, you know, really grounded in love and respect and kindness came from her," Hurley said.
The Bristol Bay victory remains subject to ongoing litigation under the current administration. Hurley noted that the Trump administration has so far continued to defend the EPA’s action in court while the tribes pursue legislation to address the other 20 active mining claims throughout the watershed.
These outlets didn't split into competing frames — coverage was uniform.
Retired pilot Chesley Sullenberger said on July 14, 2026, that he has early-stage Alzheimer’s disease. He described initial symptoms and expressed resolve to face the condition with his family.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.